FDA Approval Summary: Sonidegib-Letter
Clin Cancer Res
.
2017 Oct 1;23(19):5993.
doi: 10.1158/1078-0432.CCR-17-1460.
Authors
Bishal Gyawali
1
,
Yuichi Ando
2
Affiliations
1
Department of Clinical Oncology and Chemotherapy, Nagoya University Hospital, Japan. bishalg@med.nagoya-u.ac.jp.
2
Department of Clinical Oncology and Chemotherapy, Nagoya University Hospital, Japan.
PMID:
28972085
DOI:
10.1158/1078-0432.CCR-17-1460
No abstract available
Publication types
Letter
Comment
MeSH terms
Biphenyl Compounds
Carcinoma, Basal Cell*
Humans
Pyridines
Skin Neoplasms*
Substances
Biphenyl Compounds
Pyridines
sonidegib